SAN DIEGO--(BUSINESS WIRE)--Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada”), a problem-solving innovator that takes on complex, multi-disciplinary challenges in healthcare, climate technology, clean energy, and precision manufacturing, announced today that its healthcare division, Genefic Wellness Group, is launching a new company, Genefic Infused Clinics (“Infused”), to offer alternative therapies for post-traumatic stress disorder, depression, anxiety, and chronic pain.
With ongoing evidence supporting the effectiveness of non-traditional therapies such as ketamine infusion, many individuals are trying these innovative approaches toward healing. Infused will cater to the needs of these patients, including those who are failing traditional medication-based therapies for these chronic conditions.
“Genefic Infused Clinics are a lifeline for anyone suffering from a debilitating condition like PTSD or anxiety,” said Dan Riley, Genefic Wellness Group’s President and Chief Operating Officer. “Our therapies are a safe and effective alternative to SSRIs and other traditional treatments which are not working for so many patients.”
The infusion experience will be fully immersive, with each patient receiving personalized, private care as well as a recovery process after completion. Patients will undergo therapy in a dedicated infusion room and then be moved to a separate recovery room for a calming, peaceful recovery.
While Genefic Infused Clinics will provide non-traditional therapies, each location will eventually offer classic infusion services including vitamins and antioxidants for hydration, energy, and general wellness.
The first Infused clinic is expected to open its doors in the coming weeks. It will operate at the site of an already well-established health and wellness clinic in Poway, a community in San Diego’s north county.
About Genefic Wellness Group
With a dedicated commitment to health and wellness and improved patient care, Genefic Wellness Group delivers with bold ingenuity. Genefic companies create key products and services and build comprehensive solutions that provide better health outcomes through reimagined healthcare systems. From virus and disease screening capabilities to pharmaceutical goods and holistic wellness clinics, Genefic creates health innovations that make positive impacts around the world. To learn more, visit www.genefic.com.
About Dalrada Financial Corporation
Dalrada Financial Corporation (OTCQB: DFCO) is a progressive organization that drives innovation to impact people, businesses, and the planet positively. The company owns and operates a global group of healthcare, climate technology, clean energy, and precision manufacturing companies and produces disruptive technology products and services that mitigate the negative impact of climate change.
Dalrada companies are on the leading edge of developing and applying innovative eco-sensitive next-generation health, science, engineering, and technology, serving a broad range of industries and governments. The company’s products and services significantly reduce energy costs and remove barriers for its clients, creating a more sustainable and prosperous future.
Dalrada’s subsidiaries and strategic partners operate in the United States, United Kingdom, India, Malaysia, and Spain and are centrally managed from the company’s San Diego, CA headquarters.
Statements in this press release are not historical facts. The statements are forward-looking, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations regarding these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the US Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.